OraSure Technologies Inc
Change company Symbol lookup
Select an option...
OSUR OraSure Technologies Inc
BE Bloom Energy Corp
UUUU Energy Fuels Inc
SAVA Cassava Sciences Inc
RAMP Liveramp Holdings Inc
TRUL Trulite Inc
SNA Snap-On Inc
QYLD Global X NASDAQ 100 Covered Call ETF
DWSN Dawson Geophysical Co
JNJ Johnson & Johnson

Health Care : Health Care Equipment & Supplies | Small Cap Growth
Company profile

OraSure Technologies, Inc. (OraSure) is a medical device company that develops, manufactures, and markets medical devices and diagnostic products. The Company's products include molecular sampling kits for the genome and microbiome services and analytics, rapid diagnostics for infectious disease, and tests for substance abuse. OraSure’s segments include Diagnostics segment and Molecular Collection Systems segment. The Diagnostics business primarily consists of the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices. The Molecular Solutions business consists of the manufacture and sale of kits that are used to collect, stabilize, transport and store biological samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, infectious disease diagnostics, pharmacogenomics, personalized medicine, microbiome and animal genetics markets.

Day's Change
0.0199 (0.18%)
B/A Size
Day's High
Day's Low

Today's volume of 164,227 shares is on pace to be much lighter than OSUR's 10-day average volume of 472,968 shares.


HIV Diagnostics Market Revenue to Cross USD 760 Mn by 2027: Global Market Insights Inc.

5:00 am ET August 10, 2021 (PR Newswire) Print

According to the latest report, "HIV Diagnostics Market by Test Type (Antibody Test, Viral Load Test, CD4 Test), End-use (Diagnostic Laboratories, Hospitals & Clinics, Home Settings), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2027", by Global Market Insights Inc., the market valuation of HIV diagnostics will cross $790 million by 2027. Technological improvements and the increasing prevalence of HIV in developing and underdeveloped countries will foster the market growth.

HIV is one of the globe's greatest serious public health challenges. Despite numerous advances in scientific understanding of HIV and its treatment and prevention, many people with HIV still do not have proper access to the care, treatment, and prevention. Therefore, government and other non-government organizations play a crucial role in the prevention of HIV/AIDS throughout the globe. Government in different countries undertakes numerous initiatives to develop better healthcare infrastructure for improved patient care as well as management. India's AIDS control program is a success story worldwide. Similarly, the National AIDS Control Program is executed for the control and prevention of AIDS in India. Hence, numerous such ingenuities undertaken by the Indian Government and others will push the industry growth in India. However, growing awareness about safe sex and early disease testing is likely to reduce the number of cases in the APAC region.

Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/491

The CD4 test segment in the HIV diagnostics market is estimated to showcase around 0.2% growth rate through 2027. CD4 test measures a number of CD4 cells in a patient's body, and these cells move throughout the body to find as well as destroy bacteria or a virus. A standard CD4 count is from 500-1,200 cells/mm3 in teens and adults. The CD4 test is also used for routinely monitoring the severity of the disease throughout the treatment period. The recurring use of CD4 tests in HIV patients undergoing ART will affect the market expansion.

The HIV diagnostics market for the home settings segment accounted for around USD 42 million in 2020. According to the CDC, it is predicted that more than 1.1 million individuals in the U.S. are suffering with HIV. HIV screening if the foremost key to controlling the virus worldwide. If individuals are concerned regarding their privacy, a home testing kit has been approved and evaluated by the FDA. The OraQuick In-Home HIV Test is the only HIV self-test approved by the U.S. Food and Drug Administration that individuals can use to test themselves at home. Therefore, the availability of this self-test worldwide will propel the segment growth.

Asia Pacific HIV diagnostics market held over 29% of revenue share in 2020. The presence of numerous industry leaders and favorable government initiatives and programs including NACP in this region will escalate the market progression. Furthermore, the increasing usage of antibody tests in countries like India, China, Thailand, and Malaysia, among others, and rising healthcare spending are some of the factors proving beneficial for the regional expansion. However, the number of HIV cases are expected to reduce in the next decade.

Request a customization of this research report @ https://www.gminsights.com/roc/491

Some of the eminent players operational in the HIV diagnostics market include OraSure Technologies, Chembio Diagnostics, Abbott Laboratories, Cepheid, BD, BIONEER CORPORATION, Omega Diagnostics, Roche, Qiagen and Biomerieux, among others. The companies are focusing on numerous strategies that help the company increase its revenue share internationally.

Table of Contents (ToC) of the report:

Chapter 3 HIV Diagnostics Market Insights

3.1 Industry segmentation

3.2 Industry landscape, 2016 - 2027

3.3 Industry impact forces

3.3.1 Growth drivers

3.4 Growth potential analysis

3.4.1 By test type

3.4.2 By end-use

3.5 Regulatory landscape

3.6 Porter's analysis

3.7 Competitive landscape, 2020

3.7.1 Competitive matrix analysis, 2020

3.8 PESTEL analysis

Browse Complete Table of Contents (ToC) @ https://www.gminsights.com/toc/detail/hiv-diagnostics-market

About Global Market Insights Inc.

Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients penetrative insights and actionable market data specially designed and presented to aid strategic decision-making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

Contact Us:

Arun HegdeCorporate Sales, USAGlobal Market Insights Inc.Phone: 1-302-846-7766Toll Free: 1-888-689-0688Email: sales@gminsights.com

Related Images

hiv-diagnostics-market-growth.png HIV Diagnostics Market Growth Predicted at 0.4% Through 2027: GMI The CD4 test segment in the HIV diagnostics market is estimated to showcase around 0.2% growth rate through 2027.


View original content to download multimedia:https://www.prnewswire.com/news-releases/hiv-diagnostics-market-revenue-to-cross-usd-760-mn-by-2027-global-market-insights-inc-301351718.html

SOURCE Global Market Insights Inc.


comtex tracking


Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.